Evaggelismos

Athens 106 76

0 studies enrolling now · 1 studies all time

What they study most

Marginal Zone Lymphoma, Relapsed/Refractory Follicular Lymphoma

Studies at this site

• A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma — Running, not enrolling